Article Name Global/International
The FDA Is Phasing Out Animal Testing. Our Replacements Must Catch Up Fast.
In April, Health Secretary Robert F. Kennedy Jr. announced plans to dramatically reduce animal testing at U.S. health agencies. The FDA followed with a commitment to phase out animal studies in areas like monoclonal antibody development, favoring in vitro systems and artificial intelligence instead.
04th August, 2025
Demetra Launches Global Spine Division Following Strategic Acquisition of OrthoFundamentals
With the formation of Demetra Spine and recent acquisitions in the US and Europe, Demetra accelerates its mission to revolutionise spinal surgery through infection-reducing, single-use technologies designed for minimally invasive, value-based care.
04th August, 2025
Galaxy Therapeutics Opens New 9,200 Sq. Ft. Facility to Support Global Scale-Up of Brain Aneurysm Solutions
Equipped with ISO Class 7 cleanrooms and expanded R&D capacity, the new site accelerates Galaxy’s path to commercial readiness and global distribution of its breakthrough neurovascular technologies.
31st July, 2025
RIVANNA Secures $9.92M BARDA Funding to Fast-Track AI-Powered Fracture Detection System
With total federal support exceeding $52M, RIVANNA accelerates development of CADe/x — an AI-driven diagnostic tool poised to transform musculoskeletal care through automated ultrasound image analysis and real-time fracture triage.
31st July, 2025
ClariMed Achieves ISO 13485:2016 Certification, Strengthening Global Medical Device Development Capabilities
Milestone underscores ClariMed’s commitment to quality excellence and reinforces its position as a trusted partner in navigating complex global regulatory landscapes
30th July, 2025
TrilliumBiO and T-NeuroDx Partner to Advance Blood-Based Diagnostics for Early Alzheimer’s Detection
Strategic collaboration aims to accelerate validation and commercialisation of non-invasive tests, enabling earlier, more accessible diagnosis of Alzheimer’s disease
30th July, 2025
Quasar Medical Establishes Global Headquarters in Singapore to Drive MedTech Innovation and Global Growth
Strategic relocation from Hong Kong strengthens ties to Asia’s thriving MedTech ecosystem, enhances collaboration with global partners, and supports ambitious expansion plans
30th July, 2025
Johnson & Johnson MedTech Launches VIRTUGUIDE™ System to Transform Bunion Surgery with AI Precision
AI-powered, patient-matched solution aims to simplify Lapidus procedures and enhance surgical outcomes
30th July, 2025
MD Anderson and TOPPAN Forge Alliance to Advance invivoid™ 3D Organoid Technology for Personalized Cancer Therapy
Partnership aims for CAP/CLIA certification of organoid-based assay to guide patient-specific treatment decisions; $10 million investment to fuel clinical validation across multiple cancer types
30th July, 2025
How the FDA’s 510(k) Pathway and Risk-Based Oversight Are Shaping the Future of Medical Device Regulation
By aligning regulatory rigour with technological complexity, the FDA safeguards public health while accelerating access to life-changing medical innovations through adaptive pathways and total lifecycle vigilance
30th July, 2025
Surgical Safety Technologies Introduces AI-Powered Kinematic Analysis in OR Black Box
First camera-agnostic motion tracking solution for laparoscopic surgery delivers real-time insight into surgical technique and proficiency across all devices and operating rooms
30th July, 2025
Stryker’s Inari Division Debuts InThrill Thrombectomy System
First and only purpose-built solution delivering rapid and complete luminal clot removal in small vessel and arteriovenous access cases
30th July, 2025
Siemens Healthineers Leads the Way in Laboratory Sustainability with ACT Ecolabel Certification for Over 150 Diagnostic Reagents
First in the industry to achieve dual certification for both reagents and analysers within its Atellica portfolio
30th July, 2025
Athena Diagnostics Introduces Advanced Genetic Test to Detect Hidden Causes of Ataxia
Developed with PacBio's PureTarget technology, the new test enhances identification of complex DNA repeat expansions to support accurate diagnosis and care for patients with neurological disorders
30th July, 2025
Aptitude Medical Secures $9M BARDA Partnership to Advance Rapid Filovirus Diagnostic for Ebola and Marburg Detection
New Metrix Filovirus Panel to deliver 30-minute, lab-quality results from blood samples in remote and point-of-care settings—marking a pivotal step in global outbreak preparedness.
29th July, 2025
Qynapse Unveils Promising AI-Powered Advances in Alzheimer’s Imaging and Prediction at AAIC 2025
Breakthrough findings for QyScore® and QyPredict® highlight enhanced accuracy in brain segmentation and early identification of cognitive decline, paving the way for improved clinical trials and patient outcomes in Alzheimer’s disease.
29th July, 2025
Stereotaxis Secures FDA Clearance for MAGiC Sweep Catheter
New magnetic ablation catheter designed to enhance precision and reach in robotic electrophysiology procedures across the U.S.
28th July, 2025
Quanterix Unveils Next-Generation p-Tau 205 and p-Tau 212 Assays to Propel Alzheimer’s Research
Launched at AAIC 2025, the ultra-sensitive assays aim to improve early detection, disease monitoring, and biomarker discovery in neurodegenerative research.
28th July, 2025
Medtech Special
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer